株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

中国の医療機器有害事象の報告・監視・再評価に関するガイドブック

Latest Chinese Guidebook for Medical Device Adverse Events Reporting, Monitoring and Re-Evaluation (2019 Edition)

発行 Access China Management Consulting 商品コード 298122
出版日 ページ情報 英文 43 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
中国の医療機器有害事象の報告・監視・再評価に関するガイドブック Latest Chinese Guidebook for Medical Device Adverse Events Reporting, Monitoring and Re-Evaluation (2019 Edition)
出版日: 2019年01月22日 ページ情報: 英文 43 Pages
概要

当レポートでは、中国で施行された「医療機器有害事象の有害事象監視と再評価管理方法」を調査し、中国の医療市場の背景・現状、医療機器有害の報告・監視・再評価の一般規則、規制当局とその機能、各種関連事業者に課せられる義務、販売承認取得者の取るべき準備・対策などをまとめています。

第1章 エグゼクティブサマリー

第2章 中国の医療市場の環境・急激に変化する法規制上の枠組み:外資・多国籍医薬品・医療機器製造業者にとっての市場機会と課題

  • 中国の医療市場の環境
  • 法規制上の枠組みに急激な変化をもたらす要因

第3章 医療機器有害の報告・監視・再評価の一般規則

  • 定義
    • 医療機器販売承認取得者
    • 医療機器有害事象
    • 重傷
    • 医療機器グループ有害事象
    • 医療機器有害事象の監視
    • 医療機器の主な監視
    • 医療機器の再評価
    • ユーザー施設
    • 医療・保健機関
    • 医療機器の登録・記録
  • 医療機器有害の報告・監視・再評価の一般規則

第4章 規制当局とその機能

  • 医療機器有害事象監視情報ネットワーク
  • 規制当局の義務

第5章 MA取得者の義務

第6章 医療機器販売業者・医療機器ユーザー施設の義務

第7章 医療機器有害事象の報告・評価

  • 基本要件
  • 医療機器有害事の報告
    • 個々の事例の有害事象の報告
    • グループの有害事象の報告
    • 定期的なリスク評価の報告
  • 販売承認取得者の医療機器有害事象報告の全体的プロセス

第8章 主な監視の実行方法

第9章 リスクコントロール

第10章 再評価

第11章 監督・検査機関

第12章 医療機器有害事象報告・監視のための監視ネットワーク:概要

目次
Product Code: ACMC2019010001

Executive Summary

China is one of the fastest growing global economies with one fifth population in the world. Nowadays, China has become the world's second largest healthcare market after the United States. Along with sustained economic and population growth, and rapid population aging, the Chinese healthcare market has maintained annual compound growth rate above 16 % since 2010s. The statistical data showed that scale of the Chinese healthcare market has reached RMB 6464.1 billion (about equivalent to US$973.5 billion) by 2017. Among them, the total value of medical device sales was RMB 663.2 billion (US$95.2 billion) with annual compound growth rate of 20.27% by 2017. Medical devices have been widely used in the process of disease prevention, diagnosis, therapy, care and rehabilitation. However, large and medium-sized medical devices, high-end medical equipments and high-value medical materials are mainly relying on imported, such as the high-tech and high-valued imaging systems and navigation and positioning systems. Facing a gigantic population and rapid population aging, the Chinese government, on one side, accelerated the priority approval of innovative medical devices and relaxed the market access for overseas medical devices, on other side, intensified the supervision and administration for medical devices at the post-marketed. In recent years, China's fast-track approval time is much shorter than any other country, which attracts more and more overseas medical device manufacturers to enter the Chinese healthcare market. Undoubtedly the Chinese healthcare market of nearly 1.4 billion populations is the huge business opportunities for the overseas medical device manufacturers. At the same time, the Chinese regulatory authorities are changing regulatory framework to intensify the supervision and administration. The Chinese "State Administration for Market Regulation" and the "National Health Commission" jointly issued the latest version of "Measures for Medical Device Adverse Event Monitoring and Re-evaluation" in August 2018, which has been implemented on January 1, 2019. This is challenge to overseas medical device manufacturers. To capture the huge business opportunities of the Chinese healthcare market and seize a larger part of Chinese healthcare market, how do the foreign medical device manufacturers in compliance with the latest Chinese regulations on medical devices? How do the overseas medical device manufacturers operate business smoothly in China? Most importantly, overseas and multinational medical device manufacturers should always stand ready to respond to further regulation and policy changes occurred in China.

The overseas and multinational medical device manufacturers and their senior executive officers engaging in regulatory affairs need a thorough knowledge of the Chinese regulations for medical device adverse event reporting, monitoring and re-evaluation. China's regulatory approach and culture are unique.

Latest Chinese Guidebook for Medical Device Adverse Events Reporting, Monitoring and Re-Evaluation (2019 Edition) is an essential resource for overseas and multinational medical device manufacturers to handle the medical device adverse event reporting, monitoring and re-evaluation smoothly in China, which provided a detailed guidance of comprehensive and thorough knowledge of the Chinese medical device adverse event reporting, monitoring and re-evaluation regulations.

This guidebook is organized as follows. Chapter 2 provides a brief description for the China's healthcare market landscape and rapidly changing regulatory framework as background for audience. Chapter 3 introduces the general regulations for medical device adverse event reporting, monitoring and re-evaluation. Chapter 4 introduces the Chinese regulatory authorities and their respective functions and the Chinese huge medical device adverse event monitoring information network. Chapter 5 expounds the marketing authorization holders' duties and obligations, which is important for the overseas and multinational medical device manufacturers and the agents within the territory of China designated by the overseas medical device manufacturers, because they must fulfill these duties and obligations that are stipulated by the Chinese regulatory authorities. Chapter 6 expounds the medical device distributors' and medical device user facilities' duties and obligations, which is important for the distributors within the territory of China of the overseas and multinational manufacturers of imported medical devices, because they must also fulfill their duties and obligations that are stipulated by the Chinese regulatory authorities. Chapter 7 elaborates the medical device adverse event reporting and evaluation, from the basic requirements, the different types of medical device adverse event reporting, and the time limitations for different types of medical device adverse event reporting to an entire process of medical device adverse event reporting, which is important for the overseas and multinational manufacturers of imported medical devices and the agents within the territory of China designated by the overseas medical device manufacturers, because they must be in compliance with these regulations. Chapter 8 introduces how Chinese regulatory authorities implement the key monitoring on certain medical devices. Chapter 9 elaborates that the marketing authorization holders should adopt what risk control measures under what circumstances and report to the drug regulatory authorities. Chapter 10 elaborates that the marketing authorization holders should proactively conduct the re-evaluation under what circumstances and report to the drug regulatory authorities. Chapter 11 introduces that the Chinese regulatory authorities will carry out the focusing inspections on the marketing authorization holders under what circumstances. Chapter 12 describes and sketches a panoramic view for the Chinese network for medical device adverse event reporting and monitoring.

The audiences of this guidebook are the overseas medical device companies wishing to enter into the Chinese medical device market, and the multinational medical device companies have penetrated into the Chinese medical device market, and their senior executive officers engaging in regulatory affairs expecting to understand the latest Chinese regulations on medical device adverse events reporting, monitoring and re-evaluation. After having skimmed through this guidebook, audiences can clearly acquire a comprehensive and thorough knowledge of the latest Chinese regulations on medical device adverse events reporting, monitoring and re-evaluation. Access China Management Consulting Ltd hopes this guidebook, based on the full and accurate regulations, can guide overseas and multinational medical device manufacturers to achieve a successful entry into the Chinese medical device market, and smoothly operate their companies in China.

Table of Contents

Chapter 1 Executive Summary

Chapter 2 China's Healthcare Market Landscape and Rapidly Changing Regulatory Framework: Opportunities and Challenges for Overseas and Multinational Pharmaceutical and Medical Device Manufacturers.6

  • 2.1. China's Healthcare Market Landscape.6
  • 2.2. What is cause to drive the regulatory framework rapid Change?.7

Chapter 3 General Regulations for Medical Device Adverse Event Reporting, Monitoring and Re-evaluation.11

  • 3.1. Definitions.11
    • 3.1.1. Medical Device Marketing Authorization Holders.12
    • 3.1.2. Medical Device Adverse Event.12
    • 3.1.3. Serious Injuries.12
    • 3.1.4. Medical Device Group Adverse Event.12
    • 3.1.5. Medical Device Adverse Event Monitoring.12
    • 3.1.6. Key Monitoring of Medical Devices.12
    • 3.1.7. Re-evaluation of Medical Devices.13
    • 3.1.8. User Facilities.13
    • 3.1.9. Medical and Health Institutions.13
    • 3.1.10. Medical Device Registration and Recordation.13
  • 3.2. General Regulations for Medical Device Adverse Event Reporting, Monitoring and Re-evaluation.13

Chapter 4 Regulatory Authorities and their Functions.14

  • 4.1. Medical Device Adverse Event Monitoring Information Network.14
  • 4.2. Regulatory Authorities' Duties and Obligations.16

Chapter 5 MA Holders' Duties and Obligations.18

Chapter 6 Medical Device Distributors' and Medical Device User Facilities' Duties and Obligations.19

Chapter 7 Medical Device Adverse Event Reporting and Evaluation.20

  • 7.1. Basic Requirements.20
  • 7.2. Medical Device Adverse Event Reporting.23
    • 7.2.1. Individual Case Adverse Event Reporting.23
    • 7.2.2. Group Adverse Event Reporting.25
    • 7.2.3. Periodic Risk Assessment Reporting.28
  • 7.3. An Entire Process of Medical Device Adverse Event Reporting for MA Holder.30

Chapter 8 Key Monitoring.32

Chapter 9 Control of Risk.33

Chapter 10 Re-Evaluation.36

Chapter 11 Supervision and Inspection.39

Chapter 12 An Overview of Chinese Monitoring Network for Medical Device Adverse Event Reporting and Monitoring

List of Figures

  • Figure 7.3. An Entire Process of Medical Device Adverse Event Reporting for MA Holder
  • Figure 12.1.An Overview of Chinese Monitoring Network for Medical Device Adverse Event Reporting and monitoring
Back to Top